To further understand the roles of metabolic enzymes in a poorly understood neoplasm with dismal prognostic outcomes, this study showcases the utility of a genomics platform to understand the association between ketolytic and glycolytic gene expression profiles, MYCN amplification, INSS stage progression and event‐free survivability in NB. This evidence concerns the gene MYCN and neuroblastoma.